1-20 of 36
Keywords: Superficial bladder cancer
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas
European Urology (1992) 21 (Suppl. 2): 35–40.
Published Online: 11 August 2017
...A. Steg; S. Adjiman; B. Debré Bacillus Calmette-Guérin (BCG) immunotherapy represents a valuable treatment in the management of superficial bladder cancer, but the therapy is not without its risks. A total of 220 patients have been included in a review of local and systemic side effects associated...
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (1992) 21 (Suppl. 2): 22–27.
Published Online: 11 August 2017
... with better results. 11 8 2017 BCG Superficial bladder cancer 1992 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (1990) 17 (2): 113–118.
Published Online: 11 August 2017
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Superficial bladder cancer Risk factors Adjuvant topical therapy Survival rate Eur Urol 1990;17:113-118 1608015 © 1990 S. Karger AG, Basel...
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (1985) 11 (1): 1–5.
Published Online: 11 August 2017
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prediction Progression Superficial bladder cancer Clinical Papers Eur. Urol. 11: 1-5(1985) © 1985 S. Karger AG...
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (1988) 15 (1-2): 40–42.
Published Online: 11 August 2017
..., Spain 1606295 Key Words. Bladder cancer Superficial bladder cancer Prostatic urethra recurrence Abstract. A comparative retrospective study was performed on 100 patients who had undergone transurethral resection of a superficial bladder tumor (Ta-Ti) with no associated carcinoma in situ (group 1...
Journal Articles
Subject Area:
Further Areas
European Urology (1990) 17 (1): 17–19.
Published Online: 11 August 2017
...C.D. Vera-Donoso; B. Llopis; F. Oliver; G. Server; M. Alonso; J.F. Jimenez-Cruz To study the efficacy, specificity and sensitivity of ultrasonography, cytology and phospholipid/fatty acid quotient (PL/FA) in the detection of recurrences in patients with superficial bladder cancer we performed...
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (1995) 27 (Suppl. 1): 13–18.
Published Online: 11 August 2017
... (BCG) could reduce toxicity without compromising efficacy. From February 1991 to June 1992, 500 patients with superficial bladder cancer(TaG2-3, T1G1-3) entered the trial. Of these patients, 252 were included in group A (BCG, 81 mg) and 248 in group B (BCG, 27 mg). There were no significant differences...
Journal Articles
Subject Area:
Further Areas
European Urology (1995) 27 (Suppl. 1): 2–8.
Published Online: 11 August 2017
...D.L. Lamm The management of superficial bladder cancer has advanced significantly in recent years. Controlled clinical trials suggest the benefits of cytotoxic chemotherapy apply primarily to well-differentiated tumours, are short-term and do not include a reduction in disease progression...
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (1989) 16 (1): 28–30.
Published Online: 11 August 2017
...B. Llopis; C.D. Vera-Donoso; J. Gallego; F. Boronat; J.F. Jiménez-Cruz 26 patients with superficial bladder cancer underwent complete removal of tumors by transurethral resection and entered a prospective trial of immunoprophylaxis with Calmette-Guérin bacillus (BCG). The entire group had recurrent...
Journal Articles
Subject Area:
Further Areas
European Urology (1984) 10 (2): 93–100.
Published Online: 11 August 2017
..., instructions or products referred to in the content or advertisements. Superficial bladder cancer BCG immunotherapy Nonspecific immunotherapy Eur. Urol. 10: 93-100 (1984) © 1984 S. Karger AG, Basel 0302-2838/84/0102-009352.75/0 BCG Vaccine in Superficial Bladder Tumours: Eight Years Later J.A...
Journal Articles